Differing phagocytic function of monocytes and neutrophils in Chagas' cardiopathy according to the presence or absence of congestive heart failure

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 37, Issue 6, 2004, Pages 447-453

  Muniz Junqueira, Maria Imaculada ^a   Mota, Lícia Maria ^a   Aires, Rodrigo Barbosa ^a   Junqueira Jr , Luiz Fernando ^b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

Author keywords

Cardiac failure; Chagas' heart disease; Monocytes; Neutrophils; Nitro blue tetrazolium test; Phagocytosis

Indexed keywords

OXYGEN RADICAL;

ADOLESCENT; ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; IMMUNITY; INFECTION RESISTANCE; MALE; MONOCYTE; NEUTROPHIL; NITROBLUE TETRAZOLIUM TEST; PHAGOCYTOSIS; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

EID: 11244288151     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822004000600004     Document Type: Article

References (53)

1. Agoston I, Dibbs ZI, Wang F, Muller G, Zeldis JB, Mann DL, Bozkurt B. Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. Journal of Cardiac Failure 8: 306-313, 2002.
2. Blum A, Miller H. Pathophysiological role of cytokines in congestive heart failure. Annual Review of Medicine 52: 15-27, 2001.
3. th edition, Saunders, Philadelphia, p. 444-463, 1992.
4. Camargo MM, Almeida IC, Pereira MES, Ferguson MAJ, Travassos LR, Gazzinelli RT. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. The Journal of Immunology 158: 5890-5901, 1997.
5. th edition America. Society for Microbiology, Washington, p. 320-328, 1997.
6. Cardoni RL, Rottenberg ME, Segura EL. Increased production of reactive oxygen species by cells from mice acutely infected with Trypanosoma cruzi. Cellular Immunology 128: 11-21, 1990.
7. Cassatella MA, Gasperini S, Russo MP. Cytokine expression and release by neutrophils. Annals of the New York Academy of Sciences 832: 233-242, 1997.
8. Celentano AM, Cappa SMG. In vivo macrophage function in experimental infection with Trypanosoma cruzi subpopulations. Acta Tropica 55: 171-180, 1993.
9. Chen T, Gotschlich EC. CGM1a antigen of neutrophils, a receptor of gonococcal opacity proteins. Proceedings of the National Academy of Sciences 93: 14851-14856, 1996.
10. Cunha-Neto E, Rizzo LV, Albuquerque F, Abel L, Guilherme L, Bocchi E, Bacal F, Carrara D, Ianni B, Mady C, Kalil J. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Brazilian Journal of Medical and Biological Research 31: 133-137, 1998.
11. Dutra WO, Gollob KJ, Pinto-DiasJC, Gazzinelli G, Correa-Oliveira R, Coffman RL, Carvalho-Parra JF. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Tiypanosoma cruzi chronic infection. Scandinavian Journal of Immunology 45: 74-80, 1997.
12. Engman DM, Leon JS. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Tropica 81: 123-132, 2002.
13. Ferreira GG, Argueles E, Oliveira-Lima AL. Depression of blood monocytes chemotaxis in human chronic Chagas disease. Revista do Instituto de Medicina Tropical de São Paulo 21: 297-301, 1979.
14. Freischlag JA, Colburn MD, Quinones-Baldrich WJ, Moore WS. Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril. Journal of Surgery Research 52: 523-529, 1992.
15. Futamura Y. Amiodarone induces two different types of disorders in mouse alveolar macrophages. Japanese Journal of Pharmacology 74: 21-28, 1997.
16. Georgiev VS, Albright JF. Cytokines and their role as growth factors and in regulation of immune responses. Annals of the New York Academy of Sciences 685: 584-602, 1993.
17. Givertz MM, Colucci WS. New targets for heart-failure therapy, endothelin, inflammatory cytokines, and oxidative stress. The Lancet 352 (suppl 1): 34-38, 1998.
18. rd edition, New York: Raven Press, p. 1287-1308, 1993.
19. Jackson G, Gibbs CR, Davies MK, Lip GYH. ABC of heart failure. Pathophysiology. British Medical Journal 320: 167-170, 2000.
20. Junqueira Jr LF. Cardiac involvement in Chagas' disease. In: Proceedings: Symposium on Cardiology in a Tropical Environment, South African Medical Research Council, Durban, p. 268-274, 1982.
21. Junqueira Jr LF. Ambulatory assessment of cardiac autonomie function in Chagas' heart disease patients based on indexes of R-R interval variation in the Valsalva maneuver. Brazilian Journal of Medical and Biological Research 23: 1091-1102, 1990.
22. Junqueira Jr LF, Beraldo PSS, Chapadeiro E, Jesus PC. Cardiac autonomic dysfunction and neuroganglionitis in a rat model of chronic Chagas' disease. Cardiovascular Research 26: 324-329, 1992.
23. Kay J, Czop JK. Enhancement of human monocyte beta-glucan receptors by glucocorticoids. Immunology 81: 96-102, 1994.
24. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clinical Microbiology Reviews 12: 210-223, 1999.
25. Kierszenbaum F, Knecht E, Budzko DB, Pizzimenti M. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi. The Journal of Immunology 112: 1839-1844, 1974.
26. Köberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Advances in Parasitology 6: 63-116, 1968.
27. Krum H. Tumor necrosis factor-α blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): unsuccessful, to be specific. Journal of Cardiac Failure 8: 365-368, 2002.
28. 4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infection and Immunity 69: 2011-2016, 2001.
29. Mann DL. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Failure Reviews 6: 71-80, 2001.
30. Mann DL, Deswal A, Bozkurt B, Torre-Amione G. New therapeutics for chronic heart failure. Annual Review of Medicine 53: 59-74, 2002.
31. Melo RC, Machado CR. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. Experimental Parasitology 97: 15-23, 2001.
32. Miller WL, Burnett Jr JC. Circulating paracrine and autocrine mechanisms in heart failure. Current Opinion in Cardiology 8: 376-382, 1993.
33. Morato MJF, Colley DG, Powell MR. Cytokine profiles during experimental Chagas' disease. Brazilian Journal of Medical and Biological Research 31: 123-125, 1998.
34. Morris SA, Tanowitz HB, Wittner M, Bilezikian JP. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 82: 1900-1909, 1990.
35. Mills KHG, McGuirk P. Antigen-specific regulatory T-cells- their induction and role in infection. Seminars in Immunology 16: 107-117; 2004.
36. Muniz-Junqueira MI, Mota LM, Aires RB, Junqueira Jr LF. Digitalis inhibit and furosemide does not change the in vitro phagocytic function of neutrophils of healthy subjects. International Immunopharmacology 3: 1439-1445, 2003.
37. Muniz-Junqueira MI, Peçanha LMF, Silva-Filho VL, Cardoso MCA, Tosta CE. Novel microtechnique for assessment of postnatal maturation of the phagocytic function of neutrophils and monocytes. Clinical and Diagnostic Laboratory Immunology 10: 1096-1102, 2003.
38. Muniz-Junqueira MI, Prata A, Tosta CE. Phagocytic and bactericidal function of mouse macrophages to Salmonella typbimurium in schistosomiasis mansoni. The American Journal of Tropical Medicine and Hygiene 46: 132-136, 1992.
39. Muniz-Junqueira MI, Santos-Neto LL, Tosta CE. Influence of tumor necrosis factor-á on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Cellular Immunology 208: 73-79, 2001.
40. Nagy AM, Vanderbist F, Parij N, Maes P, Fondu P, Neve J. Effect of the mucoactive drug nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils. Pulmonary Pharmacdtegteal Therapy 10: 287-292, 1997.
41. Ortiz-Ortiz L, Onega T, Capin R, Martinez T. Enhanced mononuclear phagocytic activity during Trypanosoma cruzi infection in mice. International Archives of Allergy Applied Immunology 50: 232-242, 1976.
42. Prata A. Chagas' disease. Infectious Diseases Clinics of North America 8: 61-76, 1994.
43. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infectious Disease 1: 92-100, 2001.
44. Rassi A Jr, Rassi A, Lillle WC. Chagas' heart disease. Clinical Cardiology 23: 883-889, 2000.
45. Schopf RE, Hanauske-Abel HM, Tschank G, Schulle-Wissermann H, Gunzler V. Effects of hydrazil group conlalnlng drugs on leukocyte functions: an immunoregulalory model for the hydralazine-induced lupus-like syndrome. Journal of Immunopharmacology 7: 385-401, 1985.
46. Sterin-Borda L, Borda E. Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia. Annals of the New York Academy of Sciences 917: 273-280, 2000.
47. Tarleton RL. Parasite persistence on the aetiology of Chagas' disease. International Journal for Parasitology 31: 550-554, 2001.
48. Torre-Amione G, Kapadia S, Lee J, Durand JB , Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704-711, 1996.
49. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annual Review of Immunology 20: 825-852, 2002.
50. Voltarelli JC, Donadi EA, Carvalho IF, Falcão RP. Lymphocyte subpopulations and neutrophil function in chronic human Chagas' disease. Revista do Instituto de Medicina Tropical de São Paulo 32: 240-248, 1990.
51. Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-α. Journal of the American College of Cardiology 22: 1897-1901, 1993.
52. World Health Organization. Control of Chagas' disease. WHO Technical Reports Series 811: 1-95, 1991.
53. Yamaoka-Tojo M, Tojo T, Inomata T, Machida Y, Osada K, Izumi T. Circulating levels of interleukin-18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. Journal of Cardiac Failure 8: 21-27, 2002.